Big pharma is trying and failing to engage with patients and has no idea how to build service models. Previous attempts to create websites that directly engage with consumers have flopped. The appallingly-named “patient-centricity” sessions at the FT Global Pharmaceutical and Biotechnology Conference suggest pharma is still trying in vain.